EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Marine Bioactive Peptides for Colorectal Cancer Therapy: Mechanisms, Therapeutic Potential, and Translational Challenges

Yueyang Lu, Guixiao Wang, Mei Zhou iD, Tianbao Chen iD, Zhimin Fan

Marine Drugs · 09.05.2026 · 24 (5) · 170

DOI: 10.3390/md24050170 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 09.05.2026. Verfasst von Yueyang Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Clinical Innovation Center for Anorectal Diseases of T.C.M., Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Aquatic Organisms, Peptides, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nanjing Municipal Health Commission, Jiangsu Province, China, Nanjing Municipal Special Fund for Health Science and Technology Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is one of the most prevalent gastrointestinal malignancies worldwide and remains a major cause of cancer-related mortality. Although current treatment strategies, including surgery, chemotherapy, radiotherapy, and targeted therapies, have improved patient outcomes, their effectiveness is frequently limited by multidrug resistance, severe adverse effects, tumour recurrence, and restricted patient applicability. Consequently, there is an urgent need to develop novel therapeutic agents with improved efficacy and reduced toxicity. Marine bioactive peptides have emerged as promising candidates for CRC therapy because of their remarkable structural diversity, unique evolutionary adaptations, and broad spectrum of biological activities. Numerous marine-derived peptides exhibit potent anti-CRC effects by inducing apoptosis, regulating cell-cycle progression, suppressing invasion and metastasis, inhibiting angiogenesis, and modulating the tumour microenvironment while generally demonstrating low toxicity toward normal cells. Despite these advantages, the clinical translation of marine peptides remains constrained by several challenges, including poor stability, rapid enzymatic degradation, limited bioavailability, difficulties in large-scale production, insufficient target characterization, and a lack of long-term safety evaluation. Recent advances in peptide engineering and pharmaceutical technology have significantly accelerated progress in this field. Strategies such as structural modification, cyclization, nanoformulation, intelligent delivery systems, and artificial intelligence-assisted peptide design have improved peptide stability, targeting efficiency, pharmacokinetic properties, and production feasibility. These technological innovations provide new opportunities to overcome the major limitations associated with marine peptide therapeutics. This review systematically summarizes the sources, structural characteristics, extraction and purification methods, molecular mechanisms, and in vitro and in vivo anti-CRC activities of marine-derived peptides. In addition, the major translational challenges and current technological solutions are critically discussed, with particular emphasis on the integration of multidisciplinary approaches for the development of next-generation marine peptide-based therapeutics for colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAquatic OrganismsPeptidesAntineoplastic AgentsHumansAnimalsTumor Microenvironment

Stichwörter der Autor:innen

anti-colorectal cancer mechanismcolorectal cancermarine bioactive peptidestranslation

Substanzen

PeptidesAntineoplastic Agents

Autor:innen und Institutionen

  • Jiangsu Clinical Innovation Center for Anorectal Diseases of T.C.M., Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China.
  • School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.

ORCID-Profile: Mei Zhou, Tianbao Chen

Förderung

  • Nanjing Municipal Health Commission, Jiangsu Province, China
  • Nanjing Municipal Special Fund for Health Science and Technology Development

Zitieren

APA

Lu, Y., Wang, G., Zhou, M., Chen, T., & Fan, Z. (2026). Marine Bioactive Peptides for Colorectal Cancer Therapy: Mechanisms, Therapeutic Potential, and Translational Challenges. Marine Drugs, 24(5), 170. https://doi.org/10.3390/md24050170

Vancouver

Lu Y, Wang G, Zhou M, Chen T, Fan Z. Marine Bioactive Peptides for Colorectal Cancer Therapy: Mechanisms, Therapeutic Potential, and Translational Challenges. Marine Drugs. 2026;24(5):170. doi:10.3390/md24050170

BibTeX
@article{Lu2026,
  author = {Lu, Yueyang and Wang, Guixiao and Zhou, Mei and Chen, Tianbao and Fan, Zhimin},
  title = {Marine Bioactive Peptides for Colorectal Cancer Therapy: Mechanisms, Therapeutic Potential, and Translational Challenges},
  journal = {Marine Drugs},
  year = {2026},
  volume = {24},
  number = {5},
  pages = {170},
  doi = {10.3390/md24050170}
}
Kostenlos starten →